04:34 PM EDT, 03/17/2026 (MT Newswires) -- ClearPoint Neuro ( CLPT ) reported full-year 2025 loss late Tuesday of $0.90 per diluted share, widening from a loss of $0.70 a year earlier.

Two analysts surveyed by FactSet expected a loss of $0.83.

Revenue for the quarter ended Dec. 31 was $10.4 million, up from $7.8 million a year earlier.

Two analysts polled by FactSet expected $10.1 million.

The company expects 2026 revenue of $52 million to $56 million. Two analysts expect $55.5 million.